Curadev announces research collaboration and licensing agreement with Roche

Curadev announces research collaboration and licensing agreement with Roche

New Delhi, India – Curadev Pharma Private Ltd. has entered into a research collaboration and exclusive license agreement with Roche for the development and commercialization of IDO1 and TDO inhibitors. Headquartered in New Delhi, India, Curadev Pharma Private Limited was founded in 2010. Curadev focuses on the creation and out-licensing of pre-IND assets and IND packages for drug development.
Source: Curadev (Link to full release)

About the author

Amitabh Arora

Amitabh Arora

Amitabh Arora has more than 18 years of experience promoting foreign direct investments (FDI), trade and economic relations between India and Switzerland, South Korea, United Kingdom and Canada. He is currently working as Director Key Accounts at the Greater Geneva Berne area (GGBa), the economic development agency of western Switzerland. GGBa offers a comprehensive range of services at no charge to foreign companies seeking to establish a presence in Switzerland. He is also the founder of FDITracker.com, tracking FDI developments worldwide. Amitabh has a Masters in International Business from the Indian Institute of Foreign Trade (IIFT) and a Bachelor of Business Studies (BBS) from College of Business Studies, India.

    Leave a Reply